- Home
- AXP vs JNJ Comparison
AXP vs JNJ Comparison
Compare AXP & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXP | JNJ |
|---|---|---|
| Founded | 1850 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.5B | 542.4B |
| IPO Year | 2005 | 2003 |
Fundamental Metrics
Financial Performance| Metric | AXP | JNJ |
|---|---|---|
| Price | $341.77 | $235.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 20 |
| Target Price | ★ $357.33 | $238.20 |
| AVG Volume (30 Days) | 2.6M | ★ 6.6M |
| Earning Date | 04-23-2026 | 04-14-2026 |
| Dividend Yield | 1.20% | ★ 2.36% |
| EPS Growth | 9.78 | ★ 90.50 |
| EPS | ★ 4.28 | 2.14 |
| Revenue | ★ $27,819,000,000.00 | N/A |
| Revenue This Year | $19.81 | $6.63 |
| Revenue Next Year | $8.80 | $7.43 |
| P/E Ratio | ★ $78.36 | $110.12 |
| Revenue Growth | ★ 13.44 | N/A |
| 52 Week Low | $288.34 | $149.04 |
| 52 Week High | $387.49 | $251.71 |
Technical Indicators
Market Signals| Indicator | AXP | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 69.32 | 54.44 |
| Support Level | $334.10 | $233.83 |
| Resistance Level | $349.19 | $235.50 |
| Average True Range (ATR) | 7.29 | 4.47 |
| MACD | 3.21 | 0.97 |
| Stochastic Oscillator | 98.12 | 66.40 |
Price Performance
Historical ComparisonAbout AXP American Express Company
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. It operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.